Trial intelligence / Profile preview

Intravenous lidocaine and Bispectral Index changes in cesarean section under spinal anesthesia

IRCT201608063051N10Phase 3Completed

Sponsor
Qazvin University of Medical Sciences
Start
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of lidocaine, sponsored by Qazvin University of Medical Sciences. Primary endpoint: Change in Bispectral Index (BIS). Started Dec 2015; status: completed.

02

Drugs

lidocaine

Beyond the preview

Go deeper on IRCT201608063051N10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201608063051N10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call